查看購物車
  • Simplified Chinese
  • English
  • Japanese
口腔臨床營養市場 - 2018-2028 年全球行業規模、佔有率、趨勢、機會和預測，按適應症、配銷通路、地區和競爭細分
市場調查報告書
商品編碼
1331402

口腔臨床營養市場 - 2018-2028 年全球行業規模、佔有率、趨勢、機會和預測，按適應症、配銷通路、地區和競爭細分

Oral Clinical Nutrition Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Indication, By Distribution Channel, Region and Competition
出版日期: | 出版商: TechSci Research | 英文 117 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

由於慢性病發病率的上升以及對以患者為中心的護理的日益關注，全球口腔臨床營養市場在預測期內將以令人印象深刻的速度成長。此外，營養不良和肌肉減少症和惡病質等相關疾病的日益流行也刺激了對該產品的需求。

更加注重以患者為中心的護理

對以患者為中心的護理的日益關注正在以多種方式影響全球口腔臨床營養市場的成長。以患者為中心的護理是一種醫療保健方法，重點是將患者置於護理的中心，並根據他們的個人需求和偏好客製化治療計劃。隨著患者在醫療保健決策中變得更加知情和有權，這種方法在醫療保健領域變得越來越普遍。

人們越來越關注以患者為中心的護理，這增加了對個性化營養解決方案的需求，強調品質和安全的重要性，並強調對患者教育和支持的需求，從而推動了全球口腔臨床營養市場的成長。

以患者為中心的護理正在通過增加對個性化營養解決方案的需求來影響全球口腔臨床營養市場的成長。不同醫療狀況和營養需求的患者需要不同類型的營養支持。例如，癌症患者可能需要高蛋白、高熱量飲食來維持治療期間的體重和肌肉品質，而糖尿病患者可能需要低糖飲食來控制血糖水平。隨著患者對自己的醫療保健越來越了解並需要更加個性化的護理，對可根據其特定營養需求量身定做的口服臨床營養產品的需求不斷成長。

通過日益重視口腔營養產品的品質和安全性，以患者為中心的護理正在推動口腔臨床營養市場的成長。患者越來越意識到與營養不良相關的風險，例如營養不良、脫水和胃腸道併發症。因此，他們需要高品質和安全的口服營養產品來幫助他們保持健康和福祉。對安全有效的口服臨床營養產品的需求正在推動行業創新，企業不斷開發新的和改進的配方，以滿足不同醫療狀況患者的需求。

以患者為中心的護理通過提高患者教育和支持的重要性，正在影響全球口腔臨床營養市場的成長。接受口服臨床營養產品的患者需要接受有關如何正確有效使用這些產品的教育。這包括如何將口服營養產品涵蓋日常生活、如何準備和服用以及如何監測其營養狀況的指導。患者還需要持續的支持和監測，以確保他們實現營養目標並保持健康。因此，對能夠為患者提供這種教育和支持的醫療保健專業人員的需求不斷成長，這推動了全球口腔臨床營養市場的成長。

營養不良和其他相關疾病的患病率增加

營養不良及相關疾病的患病率日益增加是推動全球口腔臨床營養市場成長的關鍵因素之一。營養不良是一種因體內缺乏必需營養素而引起的疾病，可能導致一系列健康問題，包括免疫系統減弱、傷口癒合緩慢以及生長發育受損。營養不良在患有癌症、愛滋病毒/愛滋病和糖尿病等慢性疾病的患者中尤其普遍，因為這些疾病會影響身體吸收和利用營養的能力。

隨著全球慢性病發病率持續上升，口服臨床營養產品的需求也在不斷增加。口服臨床營養產品，例如專門的腸內配方和補充劑，旨在提供營養不良或其他相關疾病患者可能無法通過常規飲食獲得的必需營養素。

營養不良及相關疾病的日益流行，加上對以患者為中心的護理和創新營養解決方案的日益關注，正在推動全球口腔臨床營養市場的成長。

可用的客製化：

根據給定的市場數據，TechSci Research 可根據公司的具體需求提供客製化服務。該報告可以使用以下自定義選項：

公司資訊

  • 其他市場參與者（最多五個）的詳細分析和概況分析。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 考慮學習的年份
    • 主要市場細分

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要行業合作夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量和驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球口腔臨床營養市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按適應症（阿滋海默症、營養缺乏症、癌症護理、慢性腎病、吞嚥困難、其他）
    • 按配銷通路（直接銷售與間接銷售）
    • 按地區
    • 按公司分類 (2022)
  • 產品圖
    • 按指示
    • 按配銷通路
    • 按地區

第 6 章：北美口腔臨床營養市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按指示
    • 按配銷通路
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲口腔臨床營養市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按指示
    • 按配銷通路
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 8 章：亞太地區口腔臨床營養市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按指示
    • 按配銷通路
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞

第 9 章：南美口腔臨床營養市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按指示
    • 按配銷通路
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲口腔臨床營養市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按指示
    • 按配銷通路
    • 按國家/地區
  • MEA：國家分析
    • 南非口腔臨床營養
    • 沙烏地阿拉伯口腔臨床營養
    • 阿拉伯聯合大公國口腔臨床營養

第 11 章：市場動態

  • 司機
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球口腔臨床營養市場：SWOT 分析

第 14 章：波特的五力分析

  • 行業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15章：競爭格局

  • 商業概覽
  • 服務內容
  • 最近的發展
  • 主要人員
  • SWOT分析
    • Abbott Laboratories, Inc.
    • Pfizer, Inc.
    • Bayer AG
    • Nestle SA
    • GlaxoSmithKline plc.
    • Baxter International Inc.
    • Otsuka Holdings, Co. Ltd.
    • Baxter International Inc.
    • Victus, Inc.
    • Danone SA(Nutricia)

第 16 章：戰略建議

簡介目錄
Product Code: 15208

Global Oral Clinical Nutrition Market is poised to grow at an impressive rate during the forecast period on account of the rising incidence of chronic diseases and an increasing focus on patient-centric care. In addition, the growing prevalence of malnutrition and related conditions such as sarcopenia and cachexia are also fueling demand for the products.

Increasing demand for products that provide essential nutrients to patients who are unable to consume adequate amounts of food through normal means. This market encompasses a wide range of products, including supplements, enteral feeding formulas, and medical foods, all designed to provide patients with the nutrients they need to support their recovery and maintain their health.

One of the key drivers of the global oral clinical nutrition market is the increasing prevalence of chronic diseases, such as diabetes, cardiovascular disease, and cancer. These conditions can lead to malnutrition, which in turn can exacerbate the patient's health problems and increase the risk of complications. As a result, healthcare providers are increasingly turning to oral clinical nutrition products to help manage these conditions and improve patient outcomes.

Another key factor driving the oral clinical nutrition market is the aging population. As the population ages, the risk of malnutrition and related conditions increases, as does the need for products that can provide essential nutrients to support overall health and well-being. This has led to a growing demand for oral clinical nutrition products that are specifically designed for elderly patients, such as high-protein supplements and fortified meal replacements.

The market for oral clinical nutrition products is also being driven by a growing focus on patient-centric care. Healthcare providers are increasingly recognizing the importance of personalized nutrition in improving patient outcomes and are turning to oral clinical nutrition products to provide patients with the nutrients they need to support their recovery and maintain their health. This trend is also being driven by the rise of value-based care models, which prioritize patient outcomes and require healthcare providers to take a more holistic approach to patient care.

Oral clinical nutrition products are constantly evolving, with new products being developed and launched to meet the changing needs of patients and healthcare providers. Nestle Health Science launched Peptamen 100 ICU, a high-protein enteral formula specifically designed for critically ill patients, in 2019. The product contains a unique blend of whey and casein proteins, which are rapidly and slowly absorbed, respectively, providing sustained protein delivery to support muscle protein synthesis. Peptamen 100 ICU is also rich in antioxidants, which are essential for supporting the immune system and reducing oxidative stress.

Abbott launched Ensure Max Protein in 2020, a high-protein oral nutritional supplement designed to support muscle health and recovery. The product contains 30 grams of protein per serving, along with essential nutrients such as vitamins and minerals. It is available in three flavors and is designed for use as a snack or meal replacement.

Danone launched Nutricia Age Care in 2021, a range of specialized oral clinical nutrition products designed to meet the unique nutritional needs of elderly patients. The range includes products such as Fortimel Energy, a high-protein oral nutritional supplement, and FortiCare, a specialized enteral formula designed to support wound healing and recovery.

Patient compliance, cost, adverse effects, product availability, and nutritional adequacy are the factors that will hamper the growth of global oral clinical nutrition market in the forecast period.

One of the biggest challenges in global oral clinical nutrition market is patient compliance. Patients may find it difficult to adhere to strict dietary regimens or may have difficulty swallowing or digesting certain products. This can lead to inadequate nutrient intake and reduced effectiveness of the intervention. Healthcare providers must work closely with patients to ensure that they understand the importance of oral clinical nutrition and are able to comply with the prescribed treatment plan. Another challenge is the cost. These products can be expensive, and insurance coverage may be limited or nonexistent. This can make it difficult for patients to obtain the necessary products, especially if they require long-term use. Healthcare providers must work with patients and their families to explore options for financial assistance and insurance coverage.

Increasing Focus on Patient-Centric Care

The increasing focus on patient-centric care is influencing the growth of the global oral clinical nutrition market in several ways. Patient-centric care is a healthcare approach that focuses on putting the patient at the center of care and tailoring treatment plans to their individual needs and preferences. This approach is becoming more prevalent in healthcare as patients are becoming more informed and empowered in their healthcare decision-making.

The increasing focus on patient-centric care is driving the growth of the global oral clinical nutrition market by increasing the demand for personalized nutrition solutions, emphasizing the importance of quality and safety, and highlighting the need for patient education and support.

Patient-centric care is influencing the growth of the global oral clinical nutrition market by increasing the demand for personalized nutrition solutions. Patients with different medical conditions and nutritional needs require different types of nutritional support. For example, a patient with cancer may require a high-protein, high-calorie diet to maintain their weight and muscle mass during treatment, while a patient with diabetes may require a low-sugar diet to control their blood sugar levels. As patients become more informed about their healthcare and demand more personalized care, there is a growing need for oral clinical nutrition products that can be tailored to their specific nutritional needs.

Patient-centric care is driving the growth of the oral clinical nutrition market by increasing the emphasis on the quality and safety of oral nutrition products. Patients are becoming more aware of the risks associated with poor nutrition, such as malnutrition, dehydration, and gastrointestinal complications. As a result, they are demanding high-quality and safe oral nutrition products that can help them maintain their health and well-being. This demand for safe and effective oral clinical nutrition products is driving innovation in the industry, with companies developing new and improved formulations that meet the needs of patients with different medical conditions.

Patient-centric care is influencing the growth of the global oral clinical nutrition market by increasing the importance of patient education and support. Patients who receive oral clinical nutrition products need to be educated on how to use them correctly and effectively. This includes guidance on how to incorporate oral nutrition products into their daily routine, how to prepare and administer them, and how to monitor their nutritional status. Patients also require ongoing support and monitoring to ensure that they are achieving their nutritional goals and maintaining their health. As a result, there is a growing need for healthcare professionals who can provide this education and support to patients, which is driving the growth of the global oral clinical nutrition market.

Increasing Prevalence of Malnutrition and other related diseases

The increasing prevalence of malnutrition and related diseases is one of the key factors driving the growth of the global oral clinical nutrition market. Malnutrition is a condition caused by a lack of essential nutrients in the body, which can lead to a range of health problems, including weakened immune systems, slower wound healing, and impaired growth and development. Malnutrition is particularly prevalent in patients with chronic diseases, such as cancer, HIV/AIDS, and diabetes, as these conditions can affect the body's ability to absorb and utilize nutrients.

As the incidence of chronic diseases continues to rise globally, the demand for oral clinical nutrition products is increasing as well. Oral clinical nutrition products, such as specialized enteral formulas and supplements, are designed to provide the essential nutrients that patients with malnutrition or other related diseases may not be able to obtain through their regular diet.

The increasing prevalence of malnutrition and related diseases, coupled with a growing focus on patient-centric care and the availability of innovative nutrition solutions, is driving the growth of the global oral clinical nutrition market.

Market Segmentation

Global Oral Clinical Nutrition Market can be segmented by indication, distribution channel, region, and competitive landscape. Based on indication, the market can be divided into Alzheimer's, Nutritional Deficiencies, Cancer Care, Chronic Kidney Disease, Dysphagia, and Others. Based on distribution channels, the market is divided into Direct Sales and Indirect Sales. Regionally, the Oral Clinical Nutrition market can be categorized into North America, Europe, Asia Pacific, South America, and Middle East & Africa.

Market Players

Abbott Laboratories, Inc., Pfizer, Inc., Bayer AG, Nestle SA, GlaxoSmithKline plc., Baxter International Inc., Otsuka Holdings, Co. Ltd., Baxter International Inc., Victus, Inc., Danone SA(Nutricia), are some of the leading players operating in the Global Oral Clinical Nutrition Market.

Report Scope:

In this report, Global Oral Clinical Nutrition Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Oral Clinical Nutrition Market, By Indication:

  • Alzheimer's
  • Nutritional Deficiencies
  • Cancer Care
  • Chronic Kidney Disease
  • Dysphagia
  • Others

Oral Clinical Nutrition Market, By Distribution Channel:

  • Direct Sales
  • Indirect Sales

Oral Clinical Nutrition Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Oral Clinical Nutrition Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Oral Clinical Nutrition Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Indication (Alzheimer's, Nutritional Deficiencies, Cancer Care, Chronic Kidney Disease, Dysphagia, Others)
    • 5.2.2. By Distribution Channel (Direct Sales v/s Indirect Sales)
    • 5.2.3. By Region
    • 5.2.4. By Company (2022)
  • 5.3. Product Map
    • 5.3.1. By Indication
    • 5.3.2. By Distribution Channel
    • 5.3.3. By Region

6. North America Oral Clinical Nutrition Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Indication
    • 6.2.2. By Distribution Channel
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Oral Clinical Nutrition Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Indication
        • 6.3.1.2.2. By Distribution Channel
    • 6.3.2. Canada Oral Clinical Nutrition Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Indication
        • 6.3.2.2.2. By Distribution Channel
    • 6.3.3. Mexico Oral Clinical Nutrition Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Indication
        • 6.3.3.2.2. By Distribution Channel

7. Europe Oral Clinical Nutrition Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Indication
    • 7.2.2. By Distribution Channel
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Oral Clinical Nutrition Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Indication
        • 7.3.1.2.2. By Distribution Channel
    • 7.3.2. Germany Oral Clinical Nutrition Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Indication
        • 7.3.2.2.2. By Distribution Channel
    • 7.3.3. United Kingdom Oral Clinical Nutrition Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Indication
        • 7.3.3.2.2. By Distribution Channel
    • 7.3.4. Italy Oral Clinical Nutrition Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Indication
        • 7.3.4.2.2. By Distribution Channel
    • 7.3.5. Spain Oral Clinical Nutrition Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Indication
        • 7.3.5.2.2. By Distribution Channel

8. Asia-Pacific Oral Clinical Nutrition Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Indication
    • 8.2.2. By Distribution Channel
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Oral Clinical Nutrition Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Indication
        • 8.3.1.2.2. By Distribution Channel
    • 8.3.2. India Oral Clinical Nutrition Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Indication
        • 8.3.2.2.2. By Distribution Channel
    • 8.3.3. Japan Oral Clinical Nutrition Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Indication
        • 8.3.3.2.2. By Distribution Channel
    • 8.3.4. South Korea Oral Clinical Nutrition Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Indication
        • 8.3.4.2.2. By Distribution Channel
    • 8.3.5. Australia Oral Clinical Nutrition Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Indication
        • 8.3.5.2.2. By Distribution Channel

9. South America Oral Clinical Nutrition Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Indication
    • 9.2.2. By Distribution Channel
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Oral Clinical Nutrition Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Indication
        • 9.3.1.2.2. By Distribution Channel
    • 9.3.2. Argentina Oral Clinical Nutrition Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Indication
        • 9.3.2.2.2. By Distribution Channel
    • 9.3.3. Colombia Oral Clinical Nutrition Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Indication
        • 9.3.3.2.2. By Distribution Channel

10. Middle East and Africa Oral Clinical Nutrition Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Indication
    • 10.2.2. By Distribution Channel
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Oral Clinical Nutrition Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Indication
        • 10.3.1.2.2. By Distribution Channel
    • 10.3.2. Saudi Arabia Oral Clinical Nutrition Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Indication
        • 10.3.2.2.2. By Distribution Channel
    • 10.3.3. UAE Oral Clinical Nutrition Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Indication
        • 10.3.3.2.2. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Oral Clinical Nutrition Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Service Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
  • 15.5. SWOT Analysis
    • 15.5.1. Abbott Laboratories, Inc.
    • 15.5.2. Pfizer, Inc.
    • 15.5.3. Bayer AG
    • 15.5.4. Nestle SA
    • 15.5.5. GlaxoSmithKline plc.
    • 15.5.6. Baxter International Inc.
    • 15.5.7. Otsuka Holdings, Co. Ltd.
    • 15.5.8. Baxter International Inc.
    • 15.5.9. Victus, Inc.
    • 15.5.10. Danone SA(Nutricia)

16. Strategic Recommendations